MO Jan 2025 52.500 call
| Previous Close | 0.8500 |
| Open | 0.9500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 52.50 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.8200 - 0.9500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.38k |
Business WireUpdate on Altria’s Pending Acquisition of NJOY Holdings, Inc.
RICHMOND, Va., May 26, 2023--Update on Altria’s Pending Acquisition of Njoy Holdings, Inc.
ZacksAltria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.
Motley Fool3 Ultra-High-Yield Dividend Stocks Billionaires Can't Stop Buying
These supercharged income stocks, with yields ranging from 7.2% to 13.6%, have been popular buys for some of Wall Street's brightest money managers.
Business WireAltria Holds 2023 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $0.94 Per Share
RICHMOND, Va., May 18, 2023--ALTRIA HOLDS 2023 ANNUAL MEETING OF SHAREHOLDERS; DECLARES REGULAR QUARTERLY DIVIDEND OF $0.94 PER SHARE
Motley FoolAltria Stock: Buy, Sell, or Hold?
Tobacco stock Altria (NYSE: MO) continually trades at a cheap valuation. Indeed, Altria's best days are probably behind it, but investors can still take advantage of the same basic recipe that has given the stock fame and its shareholders fortune. The company made waves with its investment in e-cigarette maker Juul.
Motley FoolBetter Buy: Altria vs. Procter & Gamble
This pair of consumer staples companies sit at opposite ends of the yield spectrum, but investors should also consider their risk profiles.
- Reuters
RPT-UPDATE 2-FDA issues marketing denial for 6,500 flavored e-cigarettes
The U.S. Food and Drug Administration (FDA) on Friday issued marketing denial orders to 10 companies which collectively manufacture and market about 6,500 flavored e-liquid and e-cigarette products. The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA.
ReutersFDA issues marketing denial for 6,500 flavored e-cigarettes
The health regulator said these companies cannot market or distribute the products in the U.S. and retailers who sell them risk FDA enforcement action. Any company that wants to legally market a new tobacco product in the United States must receive a written marketing order from FDA. The FDA named eight of these companies that received the denial orders, which include Imperial Vapors LLC, Savage Enterprises and Big Time Vapes, among others.
- Reuters
UPDATE 2-Altria agrees to $235 mln settlement to resolve Juul-related cases
Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
ReutersAltria agrees to $235 million settlement to resolve Juul-related cases
(Reuters) -Altria Group Inc said Wednesday that it will pay $235 million to settle at least 6,000 lawsuits accusing it of fueling a teen vaping epidemic through its former investment in e-cigarette maker Juul Labs Inc. It came shortly after San Francisco's public school district finished presenting its case against the company in a jury trial, which will now be cut short. Sarah London, one of the lead attorneys for plaintiffs in the litigation, in a statement said the deal would "provide extraordinary and truly meaningful relief for youth, parents, and governmental organizations nationwide."
Business WireAltria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation
RICHMOND, Va., May 10, 2023--Altria Announces Agreement to Resolve Vast Majority of JUUL-Related State and Federal Litigation
Motley FoolThis 5% High-Yield Stock Has More to Offer Investors
Like most tobacco companies, Philip Morris International (NYSE: PM) pays a hefty dividend. Investors should consider adding Philip Morris to their portfolio for the next 10 years. Philip Morris began as the cigarette company with non-U.S. rights to Marlboro when Altria spun it off about 15 years ago.
Motley FoolLooking for Outsized Dividend Income? Buy Altria Group Stock
Altria Group (NYSE: MO) has raised its annual payouts for 53 consecutive years, putting the tobacco giant among just 48 Dividend Kings -- companies that have raised their dividends annually for at least 50 years straight. Let's dig into why the company could be a buy for income-oriented investors. Led by its top-selling Marlboro cigarette brand and secondary brands like Parliament, Altria Group is the unquestioned leader of the U.S. combustible tobacco industry.
Business WireAltria to Host Webcast of 2023 Annual Meeting of Shareholders
RICHMOND, Va., May 04, 2023--Altria to host webcast of 2023 Annual Meeting of Shareholders.
ZacksAltria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Motley FoolShould You Buy the 5 Highest-Paying Dividend Stocks in the S&P 500?
Of the top five highest-yielding dividend stocks in the S&P 500, none have a yield of less than 7.4%. Here is some information about the five companies to help you decide if investing in them is right for you.
Motley FoolMy Biggest Red Flag About This Dividend King
Tobacco giant Altria Group (NYSE: MO) recently gave investors an updated look at the company when it held an investor event in late March. Company management laid out some goals for 2028, though shareholders might have left the event with some unanswered questions. Altria followed this up with its first-quarter earnings report about a month later.
Motley FoolAltria Once Again Shows Why It's an Unstoppable Dividend Stock, Amid Q1 Earnings
Altria (NYSE: MO) just reported its earnings for the first quarter of 2023, and it seemed to confirm the stock's unstoppability. This is notable since the government and society have actively discouraged tobacco use for decades.
Motley FoolAre These 3 Elite Dividend Stocks a Buy After Q1 Earnings?
Elite dividend stocks are highly prized assets by investors. Fortunately, quarterly earnings reports offer shareholders a window into the health of a company over the prior three months, as well as an important glimpse into what may be on the near-term horizon. Armed with this insight, here is a brief health check on three popular dividend stocks following their 2023 first-quarter earnings reports last week.
Motley FoolAltria Group (MO) Q1 2023 Earnings Call Transcript
Today's call is scheduled to last about one hour, including remarks with Altria's management and a question-and-answer session. This morning, Billy Gifford, Altria's CEO; and Sal Mancuso, our CFO, will discuss Altria's first-quarter business results.
- Thomson Reuters StreetEvents
Q1 2023 Altria Group Inc Earnings Call
Q1 2023 Altria Group Inc Earnings Call
ZacksAltria's (MO) Q1 Earnings Lag Estimates, Revenues Down Y/Y
Altria's (MO) first-quarter 2023 results benefit from increased pricing, but lower shipment volumes remain a downside.
ZacksAltria (MO) Lags Q1 Earnings and Revenue Estimates
Altria (MO) delivered earnings and revenue surprises of -0.84% and 4.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
ReutersAltria misses quarterly sales estimates on weak cigarette demand
Altria Group Inc missed sales expectations for the first quarter on Thursday, as price-sensitive consumers switched to cheaper brands of cigarettes and smokeless tobacco products. Hit by inflation, consumers have been trading down to affordable alternatives to the pricey traditional tobacco products that Altria sells, like the Marlboro brand family, which includes Special Select and Marlboro 72s. Altria has been raising the prices of its cigarettes and smoke-free products to manage higher tobacco costs, driven by lingering industry-wide supply-chain challenges and exacerbated by the Russia-Ukraine crisis.
- Reuters
CORRECTED-Altria misses quarterly sales estimates on weak cigarette demand
Altria Group Inc missed sales expectations for the first quarter on Thursday, as price-sensitive consumers switched to cheaper brands of cigarettes and smokeless tobacco products. Hit by inflation, consumers have been trading down to affordable alternatives to the pricey traditional tobacco products that Altria sells, like the Marlboro brand family, which includes Special Select and Marlboro 72s. Altria has been raising the prices of its cigarettes and smoke-free products to manage higher tobacco costs, driven by lingering industry-wide supply-chain challenges and exacerbated by the Russia-Ukraine crisis.
